Vaccinated for Covid? Join Our Paid Study
The Icahn School of Medicine at Mount Sinai is looking for healthy volunteers for a COVID-19 vaccine research study.
Located at Icahn School of Medicine at Mount Sinai
Compensation Provided
Vaccinated Individuals
Never Been Infected with COVID-19
18 to 59 Years Old
Fast Facts
About our research:
Researchers are developing a new coronavirus vaccine and need volunteers.
Researchers at Icahn School of Medicine at Mount Sinai have developed a COVID-19 vaccine with no adjuvants and no preservatives, which can be given intranasally or intramuscularly. The vaccine in this study was developed by faculty members at the Icahn School of Medicine at Mount Sinai. The medical school is actively seeking to advance this vaccine to be available for commercial use.
Participants could receive up to $3100. This 12-month program includes 9 study visits (at home or in the clinic) and a period of 5-10 days of isolation. Help further research on an investigational COVID-19 vaccine. See if you're eligible today!
Participants could receive up to $3100. This 12-month program includes 9 study visits (at home or in the clinic) and a period of 5-10 days of isolation. Help further research on an investigational COVID-19 vaccine. See if you're eligible today!
Additional Information
The objective of this study is to advance this new vaccine to be available for commercial use.
Learn more here.
Learn more here.
You are eligible if you fit the following criteria:
- Vaccinated (last dose more than 6 months ago)
- Have never been infected with the COVID-19
- Between the ages of 18 and 59 years old
- Willing and able to travel to Icahn School of Medicine at Mount Sinai for clinic visits
Our study varies in the type of interaction you will have with us based on grouping. Your program could include 9 study visits (at home or in the clinic) and a period of 5-10 days of isolation. All participants must pass a screening visit to enroll, which includes blood, saliva, urine, and nasal swab samples.
The vaccine in this study was developed by faculty members at Icahn School of Medicine at Mount Sinai. The medical school is actively seeking to commercialize this vaccine. If this clinical trial is successful, both the medical school and the faculty inventors could benefit financially. This clinical trial is being led by an independent group of faculty investigators not involved with the vaccine development and who will not financially benefit from the results of this study.
Participants can receive up to $3,100 for study completion.
There will be no cost to you to participate in the study.